SAINT PAUL, Minn., Oct. 19 /PRNewswire/ -- Cellectis plant sciences, the plant genome engineering specialist and subsidiary of Cellectis (Alternext: ALCLS), announced today that it has signed a licensing agreement with Midwest Oilseeds Inc. for plant transformation technologies. The agreement provides Cellectis plant sciences with the ability to utilize Midwest's Aerosol Beam Injector (ABI) technology for precise modification of plant genomes.
Cellectis is a leader in meganuclease-based genome engineering. Its technology has many applications in plants, allowing for the insertion, deletion or modification of gene sequences to create plants expressing new traits with added value (for example: drought resistance, enhanced nutritional qualities, disease resistance). A subsidiary dedicated to the plant applications, Cellectis plant sciences, was established earlier this year in Saint Paul (Minnesota, USA), to enable the technology's full potential in plants and to deliver it to its partners.
The Aerosol Beam Injector (ABI) technology from Midwest Oilseeds allows functional meganucleases to be delivered directly into plant cells, thus avoiding the need for DNA vectors. This approach will allow Cellectis plant sciences to modify plant genomes without integration of foreign DNA.
"Coupling the ABI system with our highly specific meganucleases should allow for the creation of desired traits of interest," said Daniel Voytas, PhD, Chief Scientific Officer of Cellectis plant sciences. "The combination of technologies will enable the development of new crop varieties through more controlled modifications."
About Cellectis plant sciences
Established in March 2010, Cellectis plant sciences is a subsidiary of Cellectis dedicated to the applications of meganucleases to plants. Its main mission is to increase and accelerate usage of Cellectis' proprietary technology in agricultural biology, broaden the company's platform to
Copyright©2010 PR Newswire.
All rights reserved